Pharmacophore-driven kinase profiling applied to the PKIS2 chemogenomic dataset

We present a data-driven and unsupervised approach for extracting 3D pharmacophore hypotheses, without prior ligand selection, from a chemogenomic kinase dataset (406 kinases and 645 compounds, PKIS2). A metric called NEM for Normalized Enrichment Measure is introduced for each pharmacophore, which quantifies change in the proportion of active compounds consistent with the pharmacophore compared to the original dataset. Based on this metric, we can identify pharmacophores associated with specific kinases and, conversely, determine all kinases that share similar metric values. This approach enables the characterization of polypharmacological profiles linked to individual pharmacophore hypotheses. We further evaluate the consistency of our results with various biological datasets, including ChEMBL, DrugBank, LINCS, KINOMEscan, and Kinobeads, showing agreement across representative case studies. This study highlights the potential of our approach for elucidating relationships between pharmacophores and kinase selectivity profiles, providing a scalable framework for exploring kinase–ligand interaction landscapes.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-03-04
DOI
https://doi.org/10.1038/s41598-026-42945-7
Primary Topic
Protein Kinase Regulation and GTPase Signaling
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacophore-driven kinase profiling applied to the PKIS2 chemogenomic dataset

Jean-Luc Lamotte, Ronan Bureau, Alban Lepailleur, Bertrand Cuissart
Scientific Reports
Protein Kinase Regulation and GTPase Signaling
article

Pharmacophore-driven kinase profiling applied to the PKIS2 chemogenomic dataset

Jean-Luc Lamotte, Ronan Bureau, Alban Lepailleur, Bertrand Cuissart
article en

Abstract

We present a data-driven and unsupervised approach for extracting 3D pharmacophore hypotheses, without prior ligand selection, from a chemogenomic kinase dataset (406 kinases and 645 compounds, PKIS2). A metric called NEM for Normalized Enrichment Measure is introduced for each pharmacophore, which quantifies change in the proportion of active compounds consistent with the pharmacophore compared to the original dataset. Based on this metric, we can identify pharmacophores associated with specific kinases and, conversely, determine all kinases that share similar metric values. This approach enables the characterization of polypharmacological profiles linked to individual pharmacophore hypotheses. We further evaluate the consistency of our results with various biological datasets, including ChEMBL, DrugBank, LINCS, KINOMEscan, and Kinobeads, showing agreement across representative case studies. This study highlights the potential of our approach for elucidating relationships between pharmacophores and kinase selectivity profiles, providing a scalable framework for exploring kinase–ligand interaction landscapes.

Scientific Reports
Centre National de la Recherche Scientifique (FR), Normandie Université (FR), GREYC (FR), Université de Caen Normandie (FR)
Agence Nationale de la Recherche
Openalex Percentile: Top 34%
Protein Kinase Regulation and GTPase Signaling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.